STATE-OF-THE-ART REVIEW IN ENDOCRINOLOGY
December 27, 2024
CASE REPORT WITH REVIEW OF LITERATURE
December 21, 2024
CASE REPORT WITH REVIEW OF LITERATURE
December 4, 2024
CASE REPORT WITH REVIEW OF LITERATURE
November 30, 2024
CASE REPORT WITH REVIEW OF LITERATURE
November 21, 2024
STATE-OF-THE-ART REVIEW IN ENDOCRINOLOGY
November 12, 2024
STATE-OF-THE-ART REVIEW IN ENDOCRINOLOGY
October 10, 2024
STATE-OF-THE-ART REVIEW IN ENDOCRINOLOGY
Featured Article Vol 72 Issue 1 (January, 2025)
ESSAY | TOWARD JES 100TH ANNIVERSARY
Vol 72 Issue 1 (January, 2025)
REVIEW
Vol 72 Issue 1 (January, 2025)
ORIGINAL
Vol 72 Issue 1 (January, 2025)
CASE REPORT WITH REVIEW OF LITERATURE
Vol 72 Issue 1 (January, 2025)
Recommendation from the Editor in Chief
It has been well recognized that inorganic iodine persistently suppresses thyroid function in some cases with Graves’ disease, and can be introduced as an alternative for patients with adverse events on antithyroid drugs. However, scientific bases are not fully elucidated and still remains empirical. In this issue, Dr. Natsuko Watanabe, an editorial board member of Endocrine Journal (EJ), contributes a well-organized, insightful narrative review focusing on this issue. The editorial team of EJ has a firm belief that all readers will be fascinated by an implicative “historical tale” around the relation between iodine and thyroid.